Stimulated recovery of perturbed haematopoiesis by inhibition of prostaglandin production - promising therapeutic strategy

Publikace: CENTRAL EUROPEAN JOURNAL OF BIOLOGY 1, 584-593 Autoři: Hofer, M., Pospisil, M. Rok: 2006


Inhibitors of prostaglandin production, designated as classical non-steroidal anti-inflammatory drugs ( NSAIDs) and acting on the base of non-selective inhibition of cyclooxygenases, have been found in numerous studies to potentiate recovery of perturbed haematopoiesis by removing the negative feedback control mediated by prostaglandins. However, classical NSAIDs show pronounced undesirable gastrointestinal side effects, which limits the possibility of their utilization for various pathophysiological states including myelosuppression. Specific cyclooxygenase-2 ( COX-2) inhibitors, targeted at selective inhibition of this inducible cyclooxygenase isoform and having much better gastrointestinal side effect profile, have been found in recent studies to retain the haematopoiesis-stimulating effects of classical NSAIDs. These results suggest that the indication spectrum of selective COX-2 inhibitors may be extended to the indication of myelosuppression of various etiology. Combining the anti-tumour and haematopoiesis-stimulating activities in a single COX-2 inhibitor may have a positive clinical impact. (c) Versita Warsaw and Springer-Verlag Berlin Heidelberg. All rights reserved.